01.31.23 -- Astellas SVP Shares DCT Tech Learnings

When the COVID-19 pandemic hit in the spring of 2020, many companies were unprepared for the changes that were about to impact their studies. Astellas is one company that was better prepared than most. The company had initiated a formalized, internal project on decentralized clinical trial (DCT) technologies and their use in clinical trials about nine months prior to the pandemic.

Delve into an illustration of how robust EDC systems fully support the operational requirements introduced by the decision to leverage eSource data.

Watch to learn how you can build a better data management and compliance monitoring plan for your COAs in your next DCT trial.

Data entry is a big part of everyday life for most CRCs. Discover the data collection process that eliminates entry errors.

Electronic data capture (EDC) is straightforward, in theory. However, not every EDC system is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.

Administering a clinical research study comes with considerable risks to achieving a successful trial. Find out how these risks are caused by challenges involving data integrity, budget overruns, collaborator productivity, and subject retention.

CRIO eConsent is unique. It checks whether patients have executed the most recent informed consent at the outset of each visit.

Sponsors and CROs can assess and mitigate risks at the study, country, and site levels, with configurable workflows embedded directly within Vault CTMS and unified with Vault eTMF.

IQVIA Complete Consent combines a friendly, feature-rich technology platform that patients and sites are eager to use, with the powerful, scalable, operational infrastructure that sponsors need to make global implementations successful.